ClinicalTrials.gg
Not yet recruitingNCT07837999Updated Sep 24, 2026

Weight Management and Health Outcomes in College Students

An interventional study of Weight Management in Weight Management, Health Outcomes and Cardiometabolic Health, sponsored by Anhui Medical University. Not yet recruiting. Open to participants aged 18 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Anhui Medical University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 26 Years
Sex
All
01

Study summary

The goal of this study is to learn if a weight management program can improve the overall health of college students.

The main questions it aims to answer are:

  • Can a weight management program help college students improve their physical health, such as weight, blood pressure, and blood sugar?
  • Can the program also improve students' daily habits, like eating and exercise, and their emotional well-being? Researchers will compare students who take part in the weight management program with students who do not, to see if the program makes a difference.

Participants in the program will:

  • Take part in regular sessions about healthy eating, physical activity, and weight management.
  • Receive support and guidance from trained staff.
  • Complete surveys and health checks before and after the program. This study is for college students who want to manage their weight and improve their health. Taking part may help students build healthier habits and feel better. The study will also help researchers understand how to design better health programs for college students in the future.
02

Conditions studied

  • Weight Management
  • Health Outcomes
  • Cardiometabolic Health
03

In context

Lead sponsor

Anhui Medical University is the lead sponsor of 104 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-26 years.
  • Currently enrolled as a college or university student.
  • Willing and able to provide .
  • Able to participate in the weight management program and complete baseline and post-intervention assessments.
  • No medical to dietary modification or physical activity.

Exclusion criteria

Exclusion Criteria:

  • Severe cardiovascular, metabolic, or psychiatric conditions that would prevent safe participation.
  • Currently participating in another weight management program or clinical trial.
  • Use of medications that significantly affect weight, appetite, or metabolism.
  • Inability to comply with study procedures or provide .
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Weight Management group

    Other: Weight Management

  • No intervention
    control group

Interventions

  • OtherWeight Management

    The intervention is a structured, multicomponent weight management program for college students. It combines health education; dietary guidance focused on regular meals, healthy food choices, and reduced snacking; physical activity promotion to increase daily steps and reduce sedentary time; self-monitoring of BMI, weight, body composition, waist circumference, blood pressure, and metabolic indicators; and behavioral support through goal setting, feedback, and social support. The program is delivered on campus by trained research staff or health educators over the study period. It differs from single-component interventions by integrating dietary, physical activity, self-monitoring, and psychosocial strategies into one program tailored to college students' daily routines.

06

What researchers measure

Primary outcomes

  1. Change in Body Mass Index (BMI)

    Unit of Measure: kg/m²

    Time frame: Time Frame: Baseline (Week 0) and immediately after completion of the 12-week intervention (Week 12).

  2. Change in Waist Circumference

    Unit of Measure: cm

    Time frame: Time Frame: Baseline (Week 0) and immediately after completion of the 12-week intervention (Week 12).

  3. Change in Systolic Blood Pressure

    Unit of Measure: mmHg

    Time frame: Time Frame: Baseline (Week 0) and immediately after completion of the 12-week intervention (Week 12).

  4. Change in Diastolic Blood Pressure

    Unit of Measure: mmHg

    Time frame: Time Frame: Baseline (Week 0) and immediately after completion of the 12-week intervention (Week 12).

  5. Change in Fasting Blood Glucose

    Time frame: Time Frame: Baseline (Week 0) and immediately after completion of the 12-week intervention (Week 12).

  6. Change in Triglyceride Levels

    Time frame: Time Frame: Baseline (Week 0) and immediately after completion of the 12-week intervention (Week 12).

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Jan 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 14, 2026
First posted
Sep 24, 2026
StartEst.
Sep 2026
Primary completionEst.
Jan 2027
CompletionEst.
Jan 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07837999
Responsible party
Mengyuan Zhao (Dr, Anhui Medical University) — Principal investigator
First posted
Sep 24, 2026
Start date
Sep 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Sep 24, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion